| 11:15 am - 3:45 pm | Registration Open | |
| 11:15 am - 12:00 pm | Networking Lunch | |
| 12:00 pm - 12:15 pm | Welcome JC Scott, President & Chief Executive Officer, PCMA Ian Spatz, National Advisor, Manatt, Phelps & Phillips | |
| 12:15 pm - 12:45 pm | Capitol Hill Perspectives on Proposals to Address Drug Costs – Closed to Media Katie McInnis, Chief Counsel, House Subcommittee on Administrative State, Regulatory Reform, and Antitrust Franci Rooney, Counsel, Senator John Cornyn, Senate Judiciary Committee | |
| 12:45 pm - 1:10 pm | Competition and Client Choices in the PBM Marketplace James Gartner, President, PerformRx
| |
| 1:10 pm - 1:35 pm | IRA Update: Implementation and Public Engagement Meena Seshamani, MD, PhD, Deputy Administrator and Director, Center for Medicare
| |
| 1:35 pm - 2:00 pm | How PBMs are Addressing Rising Healthcare Costs William Fleming, President, Pharmacy Solutions and Chief Corporate Affairs Officer, Humana | |
| 2:00 pm - 2:25 pm | How PBMs Support Providers and Patients and the Point of Prescribing Lisa Smith, Chief of Operations, Optum Rx
| |
| 2:25 pm - 2:50 pm | Using Evidence to Achieve Prescription Drug Access and Affordability Sarah K. Emond, MPP, Executive Vice President and Chief Operating Officer, Institute for Clinical and Economic Review (ICER)
| |
| 2:50 pm - 3:15 pm | Beyond Price Negotiations: How PBM Clinical Programs Work to Optimize Patient Outcomes Christine Gilroy, Chief Medical Officer, Express Scripts
| |
| 3:15 pm - 3:45 pm | Reactions and Thoughts on Current Proposals to Lower Drug Costs and Improve Competition Scott Gottlieb, M.D., Former United States Commissioner, U.S. Food & Drug Administration
|
Tuesday, April 25
